Trial · NCT07112157
Efficacy of Oxalidine and Sufentanil in Strabismus Correction
NCT07112157, Not applicable, Not yet recruiting, Henan Provincial People's Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Oxalidine and Sufentanil in Strabismus Correction. Trials, record NCT07112157. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07112157
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Oxalidine and Sufentanil in Strabismus Correction
- NCT number
- NCT07112157
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 290 participants, estimated
- Lead sponsor
- Henan Provincial People's Hospital
- Conditions
- Strabismus Surgery
- Interventions
- Oliceridine, Sulfentanil
- First posted
- 2025-08-08
- Last updated
- 2025-08-08
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Adequate rate of intraoperative analgesia | From enrollment to the end of treatment at 1 day | Definition: No body movement (body movement score ≤ 1) and no need for additional analgesics during surgical skin cutting and eye muscle traction. Evaluation method: Physical activity score (0-3 points): 0=none; 1=Mild (does not interfere with surgery); 2=Obvious (requiring intervention); 3=Severe (pause surgery). |
| Primary | Success rate of initial insertion of laryngeal mask | From enrollment to the end of treatment at 1 day | One time insertion of laryngeal mask without adjustment/replacement, and good airway sealing (normal ETCO ₂ waveform) |
| Secondary | Ocular Heart Reflex (OCR) incidence rate | From enrollment to the end of treatment at 1 day | HR decline\>20% may require atropine intervention. |
| Secondary | Hemodynamic fluctuations | From enrollment to the end of treatment at 1 day | Hypotension (MAP\<65 mmHg or decrease from baseline\>30%), hypertension (MAP\>100 mmHg) |
| Secondary | Respiratory inhibition: | From enrollment to the end of treatment at 1 day | SpO ₂\<90% or ETCO ₂\>50 mmHg |
| Secondary | Postoperative nausea and vomiting (PONV) (0-24h) | From enrollment to the end of treatment at 1 day | Rating: 0=none; 1=Mild (no need for treatment); 2=Moderate (requires antiemetic medication); 3=Severe (repeated vomiting) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07112157
GET https://conductscience.org/api/trials/v1/NCT07112157/registered